Silicone breast implant policy: FDA designee is needed to find "solution" -- Rep. Shays.
This article was originally published in The Gray Sheet
Executive Summary
SILICONE BREAST IMPLANTS: FDA DESIGNEE NEEDED TO FIND "SOLUTION" to the current regulatory status of the devices, Rep. Christopher Shays (R-Conn.) told FDA Commissioner David Kessler at an Aug. 1 hearing on silicone breast implants. The joint hearing was held by the House Government Reform/Human Resources Subcommittee, chaired by Shays, and the National Economic Growth Subcommittee.Register for our free email digests: